share_log

HC Wainwright & Co. Reiterates Buy on Amylyx Pharma, Maintains $8 Price Target

HC Wainwright & Co. Reiterates Buy on Amylyx Pharma, Maintains $8 Price Target

HC Wainwright & Co.重申对Amylyx Pharma的买入评级,维持8美元的目标价。
Benzinga ·  06/24 06:22

HC Wainwright & Co. analyst Andrew Fein reiterates Amylyx Pharma (NASDAQ:AMLX) with a Buy and maintains $8 price target.

HCWainwright&Co.分析师AndrewFein重申买入AmylyxPharma(纳斯达克:AMLX),并维持8美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发